The FasterCures Business Council brings together leaders committed to FasterCures’ mission to speed treatments and cures. Given the leadership and expertise that they have demonstrated across the health landscape, members have the opportunity to join Center-hosted events, including policy discussions, roundtables, and workshops. Business Council membership is by invitation and comprises institutional supporters of FasterCures’ work through an annual support commitment.
FasterCures’ Business Council includes members from the following organizations:
-
Alexion
-
Amgen
-
Artemis DNA
-
AstraZeneca
-
bluebird bio
-
CBC Group
-
Deloitte
-
Eli Lilly and Company
-
Exact Sciences
-
Grail
-
IQVIA
-
Jazz Pharmaceuticals
-
KPMG
-
Mayo Clinic
-
Merck
-
Novartis
-
Palantir Technologies
-
PhRMA
-
Pfizer
-
Royalty Pharma
-
Sanofi
-
Takeda
-
Vertex